Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : ½ÃÀå ºÐ¼® ¹× ¿¹Ãø-À¯Çüº°, Á¦Ç°º°, ¼­ºñ½ºº°, ±â¼úº°, ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, Àü°³º°, ÃÖÁ¾ »ç¿ëÀÚº°, ±â´Éº°(-2033³â)
AI for Organ Preservation Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Component, Application, Deployment, End User, Functionality
»óǰÄÚµå : 1632739
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 369 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,507,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 7,878,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,248,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀåÀº CAGR 14.4%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2024³â 12¾ï ´Þ·¯¿¡¼­ 2034³â 48¾ï ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀåÀº À̽ÄÀ» À§ÇÑ Àΰ£ Àå±âÀÇ º¸Á¸°ú ¿î¼Û¿¡¼­ AI ±â¼úÀÇ ÅëÇÕÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â Àå±â »ýÁ¸ °¡´É¼ºÀ» ¸ð´ÏÅ͸µÇϰí, º¸Á¸ Á¶°ÇÀ» ÃÖÀûÈ­Çϰí, ¹°·ù È¿À²À» ³ôÀ̱â À§ÇÑ AI ÁÖµµ ¼Ö·ç¼ÇÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÀÌ½Ä ¼º°ø·üÀ» ³ôÀ̰í Àå±â ³¶ºñ¸¦ ÁÙÀÌ°í »ç¿ë °¡´ÉÇÑ Àå±âÀÇ À§±â ºÎÁ·À» ÇØ°áÇϱâ À§ÇØ À̽ÄÀÇ »óȲÀ» º¯È­½Ã۰í Çコ ÄɾîÀÇ ¼º°ú¿¡ Å« Áøº¸¸¦ °¡Á®¿É´Ï´Ù.

Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀåÀº ÁÖ·Î Çコ ÄÉ¾î ±â¼úÀÇ ¹ßÀü°ú Àå±â ÀÌ½Ä ¼ö¿ä Áõ°¡·Î ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÎ¹®Àº Àå±âÀÇ »ýÁ¸ °¡´É¼º Æò°¡¸¦ °­È­ÇÏ´Â ¿¹Ãø ¹× ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ Çõ½Å¿¡ ÈûÀÔ¾î À̲ø°í ÀÖ½À´Ï´Ù. Çϵå¿þ¾î ÇÏÀ§ ºÎ¹®, ƯÈ÷ ¼¾¼­ ±â¹Ý Àåºñ´Â Àå±â º¸°ü¿¡ ÇʼöÀûÀÎ ½Ç½Ã°£ ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇÏ¿© µÎ ¹øÂ°·Î ³ôÀº ¼º°ú¸¦ °ÅµÎ¾ú½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí Àִµ¥, ÀÌ´Â °ß°íÇÑ ÇコÄɾî ÀÎÇÁ¶ó¿Í ´ë±Ô¸ð ¿¬±¸ ÅõÀÚ ¶§¹®ÀÔ´Ï´Ù. À̾î À¯·´Àº ÁöÁöÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°ú Àå±â À̽ÄÀÇ °á°ú °³¼±¿¡ ÁßÁ¡À» µÎ°Ô µÇ¾î ÀÖ¾î ±× ÇýÅÃÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì Áß¿¡¼­´Â ¹Ì±¹ÀÌ Àå±â ÀÌ½Ä ¼ö¼ú °Ç¼öÀÇ ¸¹À½°ú ±â¼ú µµÀÔÀÇ ÃËÁø¿¡ ÀÇÇØ ÅéÀÇ ½ÇÀûÀ» ¿Ã¸®°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â ÇコÄɾîÀÇ Çõ½Å°ú Àå±âÁ¦°ø ÇÁ·Î±×·¥¿¡ ÁÖ·ÂÇÏ´Â µ¶ÀÏÀÌ µÎ ¹øÂ°·Î ³ôÀº ½ÇÀûÀ» ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ªÇÐÀº Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå ÀÌÇØ°ü°èÀڵ鿡°Ô À¯¸ÁÇÑ Àü¸ÁÀ» º¸¿©ÁÝ´Ï´Ù.

2023³â Àå±âº¸Á¸À» À§ÇÑ AI ½ÃÀå ±Ô¸ð´Â 3¾ï 2,000¸¸ À¯´ÖÀ¸·Î, 2033³â¿¡´Â 5¾ï 5,000¸¸ À¯´Ö¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. Àå±â ¼ö¼Û ºÎ¹®Àº ½ÃÀå Á¡À¯À² 45%·Î 1À§¸¦ Â÷ÁöÇϰí, º¸Á¸¾×Àº 30%, Àå±â ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº 25%ÀÔ´Ï´Ù. ¼ö¼Û ºÎ¹®ÀÇ ÀÌÁ¡Àº È¿À²ÀûÀÎ ¹°·ù¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í AI ±¸µ¿ ¶ó¿ìÆÃ ½Ã½ºÅÛÀÇ ¹ßÀüÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷´Â TransMedics, Paragonix Technologies, OrganOx¸¦ Æ÷ÇÔÇϸç, °¢°¢ »ó´çÇÑ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. TransMedics´Â ÈÞ´ë¿ë Àå±â °ü¸® ½Ã½ºÅÛÀÇ Çõ½ÅÀ¸·Î ÁÖ¸ñ¹Þ°í ÀÖÀ¸¸ç Paragonix´Â ¼ö¼Û Áß Àå±âÀÇ ¾ÈÀü °­È­¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ´Â ±â¼úÀÇ Áøº¸¿Í ÇコÄɾ¼­ AI ¿ëµµ¿¡ °üÇÑ FDAÀÇ Áöħ°ú °°Àº ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©¿¡ ÀÇÇØ Çü¼ºµË´Ï´Ù. ¹Ì·¡ ¿¹Ãø¿¡¼­´Â AI ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ È®´ë¿Í Àå±â ÀÌ½Ä ³×Æ®¿öÅ©ÀÇ È®´ë°¡ ¹ÚÂ÷¸¦ °¡ÇØ ¿¬·ü 15%ÀÇ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå Àü¸ÁÀº À¯¸ÁÇϰí Àå±â »ýÁ¸À² Æò°¡¸¦ À§ÇÑ AI ÁÖµµÀÇ ¿¹Ãø ºÐ¼® °³¹ß¿¡´Â Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í ³ôÀº µµÀÔ ºñ¿ë°ú °°Àº °úÁ¦´Â ½ÃÀå °ü°èÀÚ¿¡°Ô ¿©ÀüÈ÷ ÀáÀçÀûÀÎ Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. AI°¡ Àå±â º¸Á¸¿¡ °è¼Ó ÅëÇյǴ µ¿¾È, ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ °³¼±°ú ¼¼°è Çù·Â °ü°èÀÇ È®´ë¿¡ ÁÖ·ÂÇÏ´Â °ÍÀÌ Áö¼ÓÀûÀÎ ¼ºÀå¿¡ ÇʼöÀûÀÔ´Ï´Ù.

ºÏ¹Ì´Â Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå¿¡¼­ Áß¿äÇÑ ±â¾÷ÀÔ´Ï´Ù. ¹Ì±¹Àº °í±Þ ÀÇ·á ÀÎÇÁ¶ó¿Í ÀΰøÁö´É ±â¼ú¿¡ ´ëÇÑ ¾öû³­ ÅõÀÚ·Î ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °­·ÂÇÑ Á¸Àç¿Í °­·ÂÇÑ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ÇýÅÃÀ» ¹Þ°í ÀÖ½À´Ï´Ù. Àå±â À̽ÄÀÇ ¼º°ú¸¦ Çâ»ó½ÃŰ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ´Â °ÍÀÌ AI ¼Ö·ç¼ÇÀÇ Çõ½Å°ú ä¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

À¯·´Àº µ¶Àϰú ¿µ±¹°ú °°Àº ±¹°¡µéÀÌ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç ±× µÚ¸¦ À̾ú½À´Ï´Ù. ÀÌ ³ª¶óµéÀº °Ç°­ °ü¸®ÀÇ Áøº¸¸¦ °­Á¶Çϰí Áö¿ø ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©¸¦ °¡Áö°í ÀÖ½À´Ï´Ù. AI ÅëÇÕÀ» ÅëÇÑ Àå±â º¸Á¸ ±â¼úÀÇ Çâ»ó¿¡ ´ëÇÑ ÀÌ Áö¿ªÀÇ ³ë·ÂÀº ÁÖ¸ñÇÒ ¸¸ÇÕ´Ï´Ù. ¿¬±¸±â°ü°ú ÀÇ·á Á¦°øÀÚÀÇ Çù·Â üÁ¦°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº Àå±â º¸Á¸¿¡¼­ AI¿¡ À¯¸®ÇÑ ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡µéÀº ÇコÄÉ¾î ±â¼úÀÇ ¹ßÀü¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. Àå±â ÀÌ½Ä ¼ö¿ä Áõ°¡´Â ÇコÄɾî ÁöÃâ Áõ°¡¿Í ÇÔ²² ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾ¼­ AI µµÀÔÀ» Áö¿øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ÀÌ Áö¿ªÀÇ ÀáÀç·ÂÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù.

¶óƾ¾Æ¸Þ¸®Ä«´Â Àå±â º¸Á¸À» À§ÇÑ AI ºÐ¾ß¿¡¼­ À¯¸ÁÇÑ ¼ºÀå Àü¸ÁÀ» º¸¿©ÁÝ´Ï´Ù. ºê¶óÁú°ú ¸ß½ÃÄÚ´Â ÇコÄɾ¼­ AI ¿ëµµÀÇ ÀÎÁöµµ Çâ»ó¿¡ °ßÀεǴ ÁÖ¿ä °øÇå±¹ÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ¼º°úÀÇ °³¼±°ú ÀÌ½Ä ´ë±â ½Ã°£ÀÇ ´ÜÃà¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ½ÃÀå ¹ßÀüÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ±¹Á¦ ±â¾÷¿ÍÀÇ Çù·Â ÆÄÆ®³Ê½ÊÀº ±â¼ú ÅëÇÕÀ» °­È­ÇÕ´Ï´Ù.

Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â Àå±â º¸Á¸À» À§ÇÑ AI ±â¼úÀÌ Á¡Â÷ ä¿ëµÇ°í ÀÖ½À´Ï´Ù. ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)°ú ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ÀÌ ÀÌ º¯È­¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¿Í AI ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ´Â ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â AI ¼Ö·ç¼ÇÀ» ÅëÇØ Àå±â À̽ÄÀÇ ¼º°ø·üÀ» ³ôÀÌ´Â ³ë·ÂÀÌ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ Áö¿ø Á¤Ã¥ÀÌ ½ÃÀåÀÇ °ü½ÉÀ» ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå¿¡ °üÇÑ Áß¿ä ÀλçÀÌÆ®

Á¦4Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå Àü¸Á

Á¦5Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå Àü·«

Á¦6Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå ±Ô¸ð

Á¦7Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : À¯Çüº°

Á¦8Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : Á¦Ç°º°

Á¦9Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : ¼­ºñ½ºº°

Á¦10Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : ±â¼úº°

Á¦11Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦12Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : ¿ëµµº°

Á¦13Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : Àü°³º°

Á¦14Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦15Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : ±â´Éº°

Á¦16Àå Àå±â º¸Á¸À» À§ÇÑ AI ½ÃÀå : Áö¿ªº°

Á¦17Àå °æÀï ±¸µµ

Á¦18Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The AI for Organ Preservation market is anticipated to expand from $1.2 billion in 2024 to $4.8 billion by 2034, reflecting a CAGR of 14.4%.

The AI for Organ Preservation Market encompasses the integration of artificial intelligence technologies in the preservation and transportation of human organs for transplantation. This market includes AI-driven solutions for monitoring organ viability, optimizing preservation conditions, and enhancing logistical efficiency. It aims to improve transplant success rates, reduce organ wastage, and address the critical shortage of available organs, thereby revolutionizing the transplantation landscape and offering significant advancements in healthcare outcomes.

The AI for Organ Preservation Market is witnessing remarkable growth, primarily driven by advancements in healthcare technology and increased organ transplant demand. The software segment leads, fueled by innovations in predictive analytics and machine learning algorithms enhancing organ viability assessments. The hardware sub-segment, particularly sensor-based devices, ranks as the second highest performer, offering real-time monitoring capabilities crucial for organ preservation. Regionally, North America dominates the market, attributed to its robust healthcare infrastructure and significant research investments. Europe follows, benefiting from supportive regulatory frameworks and a growing emphasis on improving organ transplant outcomes. The United States, within North America, emerges as the top-performing country, driven by a high number of organ transplant procedures and technological adoption. Germany, within Europe, stands as the second-highest performer, reflecting its strong focus on healthcare innovation and organ donation programs. These dynamics underscore a promising landscape for stakeholders in the AI for Organ Preservation Market.

In 2023, the AI for Organ Preservation Market was characterized by a volume of 320 million units, with projections to reach 550 million units by 2033. The organ transportation segment leads with a market share of 45%, followed by storage solutions at 30%, and organ monitoring systems at 25%. The dominance of the transportation segment is driven by the rising demand for efficient logistics and advancements in AI-driven routing systems. Key players in this market include TransMedics, Paragonix Technologies, and OrganOx, each holding substantial market shares. TransMedics is noted for its innovation in portable organ care systems, while Paragonix focuses on enhancing organ safety during transit.

The competitive landscape is shaped by technological advancements and regulatory frameworks, such as the FDA's guidelines on AI applications in healthcare. The market outlook is promising, with significant opportunities in developing AI-driven predictive analytics for organ viability assessment. However, challenges such as data privacy concerns and high implementation costs remain potential hurdles for market players. As AI continues to integrate into organ preservation, the focus on improving machine learning algorithms and expanding global collaborations will be crucial for sustained growth.

North America is a significant player in the AI for Organ Preservation market. The United States leads with its advanced healthcare infrastructure and substantial investment in AI technologies. This region benefits from a strong presence of key market players and robust research initiatives. The focus on improving organ transplantation outcomes drives innovation and adoption of AI solutions.

Europe follows closely, with countries like Germany and the United Kingdom at the forefront. These nations emphasize healthcare advancements and have supportive regulatory frameworks. The region's commitment to enhancing organ preservation techniques through AI integration is noteworthy. Collaborative efforts between research institutions and healthcare providers boost market growth.

Asia Pacific is emerging as a lucrative market for AI in organ preservation. Countries such as China and India are investing in healthcare technology advancements. The growing demand for organ transplants, coupled with increasing healthcare expenditure, propels market expansion. Government initiatives supporting AI adoption in healthcare further enhance the region's potential.

Latin America shows promising growth prospects in the AI for Organ Preservation sector. Brazil and Mexico are key contributors, driven by increasing awareness of AI applications in healthcare. The region's focus on improving medical outcomes and reducing transplant waiting times supports market development. Collaborative partnerships with international players enhance technological integration.

The Middle East and Africa region is gradually adopting AI technologies for organ preservation. The United Arab Emirates and South Africa are leading this transformation. Investments in healthcare infrastructure and AI research are pivotal. The region's efforts to enhance organ transplant success rates through AI solutions are gaining traction. Supportive government policies further stimulate market interest.

Key Companies

Organ AI, Preserve Tech, Life Span AI, Vita Guard, Bio Preserve, AIOrgan Care, Preservation AI, Organ Safe, Smart Preserve, Life AI, Preserve Botics, AIHealth Guard, Bio Guard AI, Vita Preserve, Organ Secure, Preserve Life AI, Health Preserve AI, Vita Safe, Bio Life AI, Organ AIPro

Sources

U.S. National Institutes of Health, World Health Organization, European Medicines Agency, U.S. Food and Drug Administration, Organ Preservation Alliance, International Society for Organ Donation and Procurement, United Network for Organ Sharing, European Society for Organ Transplantation, International Conference on Organ Transplantation and Preservation, World Congress of Nephrology, American Society of Transplantation, The Transplantation Society, National Institute for Health and Care Excellence (NICE), European Association for the Study of the Liver, American Society of Nephrology, International Liver Transplantation Society, European Renal Association, International Society for Heart and Lung Transplantation, University of California, San Francisco - Transplantation Research, Harvard Medical School - Center for Organ Preservation Research

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: AI for Organ Preservation Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: AI for Organ Preservation Market Outlook

5: AI for Organ Preservation Market Strategy

6: AI for Organ Preservation Market Size

7: AI for Organ Preservation Market, by Type

8: AI for Organ Preservation Market, by Product

9: AI for Organ Preservation Market, by Services

10: AI for Organ Preservation Market, by Technology

11: AI for Organ Preservation Market, by Component

12: AI for Organ Preservation Market, by Application

13: AI for Organ Preservation Market, by Deployment

14: AI for Organ Preservation Market, by End User

15: AI for Organ Preservation Market, by Functionality

16: AI for Organ Preservation Market, by Region

17: Competitive Landscape

18: Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â